Apobec Discovery

Overview

Targeting the key APOBEC enzymes that are a principle cause of cancer development, evolution, spread and cancer treatment resistance.

Funding and backers

Latest round
Venture round
May 2024 · 2 yr ago
Grants
$347k
1 grant · CORDIS
The money's age
Long since its last round
29 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
May 24, 2024 Raised a round Venture round Mar 6, 2023 Raised a round Venture round Nov 22, 2022 Raised a round Venture round Oct 1, 2021 Won a grant $347k · CORDIS Mar 29, 2021 Raised a round Venture round Nov 28, 2019 Raised a round Venture round Nov 1, 2018 Founded per the company register
Funding rounds
RoundDateAmountInvestorsSource
Venture round May 2024 — — find-and-update.company-information.service.gov.uk
Venture round Mar 2023 — — find-and-update.company-information.service.gov.uk
Venture round Nov 2022 — — find-and-update.company-information.service.gov.uk
Grant Oct 2021 $347k — CORDIS
Venture round Mar 2021 — — find-and-update.company-information.service.gov.uk
Venture round Nov 2019 — — find-and-update.company-information.service.gov.uk
Registers and programsofficial lists and records that name the company
Legal entity APOBEC DISCOVERY LTD Companies House
Registered 1 Nov 2018
Investors in similar startupsfunds that back the companies most like this one
BGF
backs Entia
Parkwalk Advisors
backs Entia
ARCH Venture Partners
backs HiberCell
Oxford Technology
backs Entia
Imperial College London
backs Entia
Mercia
backs CanSense
Similar startupsby what they do, their industry and backers
SirnaMed TherapeuticsConvertible Note $1.3M · 2 yr ago · Founded 2023 · 51-200 employees
SirnaMed is committed to developing innovative therapies that directly target the cause of cancer development, progression and treatment…
Cairn TherapeuticsVenture round $3M · 5 yr ago · Founded 2020 · 51-200 employees
Cairn Therapeutics: Targeting the Cancer, just the cancer. Making cancer treatment simpler and safer with CT-262.
EntiaVenture round $20M · 3 yr ago
Entia is making life better for people receiving cancer treatment.
HiberCellVenture round $60M · 7 yr ago · 51-200 employees
Developing therapies targeting adaptive-stress driven vulnerabilities to combat treatment resistance, cancer relapse, and metastasis.
Persevere TherapeuticsVenture round $1.6M · 8 mo ago · Founded 2025 · 51-200 employees
Persevere Therapeutics novel drug is focused on improving effectiveness of cancer treatments.
StratosvirVenture round · 8 mo ago · Founded 2020
Stratosvir. Revolutionizing cancer treatment through viral immunotherapy.

Financials

Total raised
$347k
Latest round
Venture - Series Unknown
Funding rounds
6
Funding rounds
Round Announced Amount
Venture - Series Unknown 2024 — Details
Venture - Series Unknown 2023 — Details
Venture - Series Unknown 2022 — Details
Grant 2021 $347k Details
Venture - Series Unknown 2021 — Details
Venture - Series Unknown 2019 — Details

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Cambridge United Kingdom
HQ